Bifurcation coronary artery disease: Current techniques and future directions (part 2)

Journal of Invasive Cardiology

Volumn 20, Issue 3, 2008, Pages 135-141

  Rizik, David G ^a   Klassen, Kevin J ^a   Hermiller, James B ^a  

^a HonorHealth and the Scottsdale Lincoln Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS;

ACUTE HEART INFARCTION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEVICE; DISEASE REGISTRY; DRUG ELUTING STENT; HEART CATHETER; HEART MUSCLE REVASCULARIZATION; INTRAVASCULAR ULTRASOUND; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS;

EID: 40449123115     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Costa RA, Lansky AJ, Abizaid A, et al. Long-term clinical follow-up of patients with de novo coronary bifurcation lesions treated with the nitinol self-expanding Biolimus A9-Eluting "AXXESS" stent - Results from the prospective, multicenter AXXESS Plus trial. Circulation 2006;114:18-II.
2. Costa RA, Lansky AJ, Abizaid A, et al. Long-term clinical follow-up of patients with de novo coronary bifurcation lesions treated with the nitinol self-expanding Biolimus A9-Eluting "AXXESS" stent - Results from the prospective, multicenter AXXESS Plus trial. Am J Cardiol 2006;98:8-S1.